According to the research report titled ‘GLOBAL Intragastric Balloon Market 2019-2028’, available with Market Study Report, global intragastric balloon market is projected to expand at 12.33% CAGR through 2028.
 

Growing obesity rate owing to unhealthy diets and inactive lifestyle is boosting demand for weight loss methods, which in turn is a key factor spurring global intragastric balloon market expansion. Short recovery time and non-invasive nature of procedure will also stimulate industry outlook. 
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552678/
 

While government investments in R&D activities to decrease obesity will aid market growth, temporary nature of treatment and stomach ulcers as side effect are poised to inhibit global intragastric balloon industry expansion.
 

The report includes information pertaining to industry share captured by each segment and their projected growth rate over the forecast period. Moreover, a comprehensive analysis of latest developments is incorporated in the document to explain lucrative opportunities in this business sphere.
 

Based on filling material, worldwide intragastric balloon industry is divided into gas-filled, and saline-filled. Speaking of component type, the market space is segmented into dual balloon, triple balloon, and single balloon. As per application range, the market is bifurcated into ambulatory surgical centers, hospitals, and clinics.
 

From the regional point of view, Asia Pacific market is speculated to grow rapidly between 2019-2028. Widespread adoption of unhealthy diet and sedentary lifestyle has resulted in high obesity rates, which then leads to diabetes, heart diseases, stroke, etc., thereby propelling demand for weight loss methods and boosting the regional market dynamics. 
 

Leading players shaping global intragastric balloon industry trends are Baronova Inc., Apollo Endsurgery Inc., Spatz FGIA Inc., ReShape Lifesciences Inc., Helioscopie, Aspire Bariatrics Inc., Districlass Medical SA, Endalis, AbbVie Inc., Obalon Therapeutics Inc., Allurion Technologies, MEDSIL, and Silimed Inc.
 

These companies have undertaken strategic moves like mergers & acquisitions, collaborations, investments in research & development, partnerships, alliances, and launch of innovative products to gain a competitive advantage and garner massive revenues.